ABSTRACT. d-Sotalol may be a clinically useful class I11 antiarrhythmic agent for controlling ventricular arrhythmias in children. Because age-related differences in repolarization currents may contribute to developmental differences in response to antiarrhythmic agents that primarily affect repolarization, the electrophysiologic effects of dsotalol were compared in Purkinje fibers from neonatal and adult dogs. Significant age-related changes characterized the antiarrhythmic profile of d-sotalol. d-Sotalol M) significantly prolonged the action potential duration of adult Purkinje fibers (310 f 8 to 380 f 7 ms, p < 0.01) and neonatal fibers (247 f 5 to 342 f 9 ms, p < 0.01).
high therapeutic success rate in the treatment of ventricular arrhythmias with antiarrhythmic drugs that significantly prolong reoolarization. class 111 effect. has broadened clinical interest in thkir use (2, 3) . The electrophysiologic effects of class 111 aitiarrhythmic agents have been studied in mature animals and adult humans (4-7), but little is understood of their effects in younger subjects (8-1 1). Furthermore, important insights into the ionic events regulating cardiac repolarization in the immature may be learned through study of the electrophysiologic effects of class 111 antiamhythmic agents that inhibit specific potassium currents. Selective inhibition of specific potassium currents may underscore their role in the overall repolarization process.
Previous developmental studies of the cellular electrophysiologic effects of antiarrhythmic drugs have observed age-related differences in responsiveness. Cardiac tjssues from immature animals demonstrate little inhibition of V,,, (an indirect measurement of fast sodium channel activity) after exposure to concentrations of local anesthetic drugs that depress adult tissues (1 2, 13). Similarly, the sensitivity of slow-response action potentials to calcium channel blockers is diminished in the neonatal age group ( 14, 15) .
Sotalol is a P-adrenergic blocking agent that prolongs action potential duration and cardiac refractoriness. Its d-isomer has little (3-adrenergic blocking activity, except at extremely high concentrations (16) . The purpose of this study was 2-fold: first, to assess age-related differences in the cellular electrophysiologic effects of d-sotalol, an antiarrhythmic drug that predominantly inhibits potassium currents (I 7, 18) . Because the electrophysiologic effects of many antiarrhythmic drugs are dependent on the experimental conditions and state of health (level of membrane potential) of the tissue studied (19) , the second purpose was to determine whether d-sotalol exerted antiarrhythmic actions in depolarized tissue not recognized in previous electrophysiologic studies on healthy myocardium with a normal resting membrane potential.
MATERIALS AND METHODS
Neonatal (0 to 10 d) and adult dogs (I to 5 y, weighing 15 to 25 kg) were anesthetized with 35 mg/kg sodium pentobarbital, given i.v. to adults and intraperitoneally to neonates. The heart was quickly removed and placed in cold oxygenated Tyrode's solution. Free-running Purkinje fiber bundles were dissected from the right and left ventricle (disconnected from any muscle attachments) and placed in a Lucite tissue bath superfused with Tyrode's solution containing (mmol/L): NaCl, 13 1 ; NaHC03, 18; CaCI,, 2.7; MgC12, 0.5; NaH2P04, 1.8; KCI, 4.0, and dextrose, 5.5. The Tyrode's solution was bubbled with 95% 0,-5% CO, and warmed to 37"C, (pH 7.33 k 0.15).
Stimuli were delivered with bipolar silver wires that were insulated to the tips with Teflon. The stimulus pulse width was 105 2 ms and the amplitude was 1.5 to 2.0 times diastolic threshold. The Purkinje fibers were impaled with 3 M KC1-filled glass capillary microelectrodes having tip resistances of 10-30 M ohms. The Purkinje fibers were paced at a cycle length of 500 rns and allowed to stabilize for 1 h before control measurements were made. After equilibration, the following transmembrane action potential characteristics were measured from photographic recordings: MDP; APA; V,.,, which was differentiated electronically; plateau height (measured from 0 potential to the peak of the plateau); APD,,; and APDI,. The slopes of phases 2 and 3 of repolarization were measured digitally from photographic enlargements of recorded transmembrane action potentials. Plateau duration was measured from the end of phase I to the beginning of phase 3. The methods used for measuring transmembrane action potential characteristics, calibrating the equipment, and recording the action potential data have been described previously (20) .
The cellular electrophysiologic effects of d-sotalol were studied in three groups of Purkinje fibers: adult free-running, adult subendocardial, and neonatal free-running fibers. To assess agerelated differences in the electrophysiologic effects of d-sotalol in similar regions of the conduction system, the response of freerunning Purkinje fibers from adult and neonatal animals was compared. Previous microelectrode studies have shown adult Purkinje fibers to have significantly longer action potential durations, compared to neonatal fibers (14) . In an attempt to minimize differences in action potential duration as a variable explaining developmental differences in drug response, comparison of the electrophysiologic effects of d-sotalol superfusion was made between adult subendocardial Purkinje fibers (shorter action potential than adult free-running fibers) and neonatal freerunning Purkinje fibers (2 1).
The Purkinje fibers were superfused with graded concentrations of d-sotalol hydrochloride (Bristol-Myers Squibb, Wallingford, CT): 1 x lo-', 1 x 1 x and 1 x M. Transmembrane action potential characteristics were recorded after an initial equilibration period of 60 min, and 25 min after each change in superfusate concentration. Steady state effects were achieved within 25 min of onset of d-sotalol superfusion.
To explore whether the effect of d-sotalol on depolarized Purkinje fibers was different from that noted in healthy tissue with a normal MDP, neonatal and adult Purkinje fibers were superfused with Tyrode's solution containing a higher KC1 concentration. MDP was depolarized from -92 mV (adult Purkinje fibers) and -85 mV (neonatal Purkinje fibers) to -64 + 1 mV, using KCI, 1 1 f 1 mM/L. The superfusate potassium concentration was changed in stepwise increments until MDP decreased to -64 + 1 mV.
Toxic efjects of d-sotalol. Thirty min after superfusion with dsotalol M, external pacing was terminated and spontaneous activity observed. After attaining a steady state spontaneous cycle length, each Purkinje fiber was paced for a 3-min period at cycle lengths between 2000 and 500 ms, beginning at a cycle length 10% less than the spontaneous cycle length. The paced rate was decremented by 200-ms intervals. At each paced cycle length, early afterdepolarizations and triggered activity were searched for.
Data analysis. Only results from experiments in which a continuous impalement was maintained throughout the superfusion protocol were analyzed. A nested analysis of variance was used to assess statistically significant differences between the two age groups (22) . When significance was found ( p < 0.05), comparisons between groups were made using Bonferroni's modification of the t test. Significance was determined at p < 0.05.
Results are expressed as the mean f SEM. Superfusion of Purkinje fibers with concentrations of d-sotalol that prolonged repolarization had no significant depressant effect on MDP, APA, or V, , , ( Table 1) .
The response of plateau height, plateau duration, and the slope of phases 2 and 3 of repolarization to d-sotalol superfusion was analyzed to further characterize the age-related differences in repolarization observed. d-Sotalol superfusion had no significant effect on plateau height in either age group: adult fibers, 0 Figure 2A demonstrates a concentration-dependent prolongation of plateau duration after d-sotalol superfusion in both age groups studied; however, the magnitude of increase in plateau duration was significantly greater for the younger age group ( p < 0.01). In addition, the threshold concentration for prolonging plateau duration in the neonatal fibers was lower (d-sotalol 1 x M). d-Sotalol had no significant effect on the slope of phase 2 repolarization in either age group (Fig. 28) . The change in the slope of late repolarization, phase 3, is shown in Figure 2C . dSotalol significantly slowed the slope of phase 3 in both age groups; however, the decrease in the slope of phase 3 was significantly greater in the neonatal fibers ( p < 0.01) and occurred at a lower threshold concentration in the younger age group (d-sotalol 1 x lo-' M).
To exclude the possibility that the enhanced responsiveness of the neonatal age group to d-sotalol was not secondary to the longer action potential duration of adult Purkinje fibers, similar experiments were performed using adult subendocardial Purkinje fibers. The APDloo of adult subendocardial Purkinje fibers (267 + 7 ms) was shorter than that observed in free-running adult strands (3 10 + 8 ms) and closer to neonatal fibers (247 * 5 ms).
The effect of d-sotalol on APDloo of adult subendocardial Purkinje fibers and neonatal fibers is presented in Figure 3 . d-Sotalol significantly prolonged APD,, in adult subendocardial Purkinje fibers. Despite similar control action potential durations, neonatal fibers again exhibited a larger increase in APDloo compared with the adult group ( p < 0.01). Action potential recordings from two experiments are shown in Figure 4 .
Toxic effects of d-sotalol. Significant age-related differences in the toxic effects of d-sotalol were observed. A strip chart recording from an adult fiber superfused with d-sotalol 1 x M is displayed in Figure 5 . In these experiments, the adult and neonatal Purkinje fibers were paced at cycle lengths ranging from 2000 to 500 ms. Short, nonsustained runs of triggered activity initiated by early afterdepolarizations were evident in the adult fibers only. Triggered activity started within 10 s of a change in cycle length. d-Sotalol induced early afterdepolarizations and triggered activity in seven of 12 Purkinje fibers and in none of the 12 neonatal fibers studied.
Eflects of d-sotalol on K+-depolarized Purkinje cells. In contrast to its limited electrophysiologic effect on repolarization in normally polarized Purkinje cells, d-sotalol exhibited membrane depressant activity in K+-depolarized Purkinje fibers (Table 2) . KC1 (I I * 1 mM) was used to produce depressed fast-response action potentials in adult and neonatal fibers. After equilibration, action potential characteristics remained stable for at least 2 h after increasing the extracellular potassium concentration (preliminary results). Once depolarized, 13 adult and 12 neonatal fibers were superfused with d-sotalol: 1 x lo-', 1 x 1 x and 1 x
M. An age-related difference in the membrane depressant effect of d-sotalol was apparent, the depressant effect being greater in adult fibers. Five of thirteen adult fibers studied became inexcitable during d-sotalol 1 x lo-' M exposure, even during maximum stimulation (100 V, 2 ms). None of the 12 d-sotalolsuperfused neonatal fibers developed enough depression to become inexcitable. In the other eight adult fibers studied, d-sotalol 1 X M significantly decreased APA from 88 & 2 to 83 + 1 mV ( p < 0.05). The decrease in APA detected in neonatal fibers (8 1 + 3 to 79 + 3 mV) was not significant. d-Sotalol significantly decreased V,,, in both adult and neonatal fibers; however, the change was significantly greater in adult fibers ( p < 0.01). Decrease of V,,, occurred at a lower threshold concentration in the adult age group (1 x lo-' M).
d-Sotalol significantly prolonged both the APDso and APDloo of K'-depolarized fibers from both age groups in a concentrationdependent manner.
Age-related differences in cardiac tissue responsiveness to antiarrhythmic drugs that predominantly inhibit sodium or calcium channel activity have previously been demonstrated (12) (13) (14) . Altered responsiveness of cardiac tissues from immature animals has important clinical implications for the therapeutic effectiveness and toxicity of antiarrhythmic agents in children. Implications deduced from experimental and clinical studies performed in mature animals or adult humans may have little validity for younger subjects. Thus, the clinical usage of antiarrhythmic agents in children may need to be modified depending on agerelated differences in pharmacokinetics and tissue sensitivity.
Class III activity of d-sotalol: evidence for maturational changes. A significant age-related difference in the class I11 electrophysiologic effect of d-sotalol was observed in this study. d-Sotalol prolonged repolarization (APDSO and APDloo) in both neonatal and adult Purkinje fibers. However, the maximum extent of action potential lengthening was greater in the younger age group (27 versus 18%). Furthermore, the threshold concentration of d-sotalol that significantly prolonged plateau duration and decreased the slope of phase 3 repolarization was lower in the newborn age group (lo-' versus M). The results are concordant with those of Xu et al. (9), who observed i.v. sotalol to prolong ventricular refractoriness in a dose-dependent manner in young puppy hearts.
Age-related differences in control action potential duration were eliminated as an explanation for these findings. In fact, the class I11 effect of d-sotalol on Purkinje fibers with shorter action potential durations was not invariably greater. Prolongation of action potential duration in adult subendocardial Purkinje fibers was less than that which occurred in adult free-running Purkinje fibers. Action potential duration in the control state was shorter in adult subendocardial Purkinje fibers than it was in adult freerunning Purkinje fibers.
d-Sotalol lengthened action potential duration by slowing the terminal phases of repolarization. The absence of effect on early repolarization was evidenced by no change in plateau height or the slope of phase 2. d-Sotalol prolonged action potential duration by lengthening plateau duration and decreasing the slope of phase 3 repolarization. In a voltage clamp study by Carmeliet (1 7), sotalol was noted to decrease the time-dependent potassium current activated during the plateau of the action potential (delayed rectifier current) and the time-independent background potassium current. Inhibition of these two potassium currents occurred at sotalol concentrations greater than lo-' M and probably accounts for the results observed in this study. Carmeliet did note that at concentrations greater than M, sotalol depressed the sodium window current. No significant effect of sotalol was evident on the slow inward calcium current.
Lengthening of plateau duration and decrease in the slove of phase 3 repola"zaiion were greater in the younger age group and occurred at a lower d-sotalol concentration. Possible explanations for the greater effect of d-sotalol noted in immature Purkinje fibers include: 1 ) a larger contribution of the delayed rectifier potassium current to action potential repolarization in the neonate (23), 2) smaller contribution of the sodium window current to action potential duration in the neonatal age group, 3 ) maturational differences in the membrane binding of d-sotalol (greater in the newborn age group), and 4) maturational differences in the access of drug to receptor sites. Voltage clamp and drugmembrane binding studies will be required to resolve these possibilities. Torsade de pointes. Torsade de pointes has been reported as a proarrhythmic complication in several clinical trials with sotalol (24, 25) . Bradycardia-dependent triggered activity has been suggested by Brachmann eL a[. (26) as one possible mechanism for drug-induced multiformed ventricular tachycardia. A high incidence (58%) of early afterdepolarizations and triggered activity was observed in this study when adult Purkinje fibers were exposed to high concentrations of d-sotalol M). In contrast, no triggered phenomenon occurred in the immature age group. If early afterdepolarizations and triggered activity are the underlying mechanism for drug-induced torsade de pointes, we may anticipate that d-sotalol treatment of children may be less likely to produce new onset arrhythmias (27, 28) . This result may seem paradoxical at first. Lengthening of action potential duration by d-sotalol was greater in the neonatal age group; however, the incidence of potentially toxic proarrhythmic effects was lower in the younger age group. The mechanism underlying drug-induced early afterdepolarizations, although not fully understood, involves a critical balance between depression of outward potassium current(s) and an increase in inward calcium current (29) . Calcium release from the sarcoplasmic reticulum has been thought to be one important source for inward current in the genesis of early afterdepolarizations (30) . Developmental morphologic data has, however, suggested that the t-tubule system and sarcoplasmic reticulum are underdeveloped in the neonatal heart (30, 31) . Despite decreasing outward potassium current in the younger age group, the insignificant contribution of the sarcoplamic reticulum as a source for inward current may explain the lower incidence of toxic effects in the neonatal group after d-sotalol exposure.
Class I activity of d-sotalol. Before this study, Cobbe el al. (32) studied the electrophysiologic actions of sotalol in a conscious canine model of myocardial infarction. These investigators found a significant increase in ischemic zone refractoriness, the mechanism of which could not be explained. The results of the present study, however, suggest that the electrophysiologic effects of d- In accord with previous developmental studies of antiarrhythmic drugs that depress the sodium current, the electrophysiologic effects of d-sotalol were significantly less in the neonatal age group (12, 13) . None of the K+-depolarized neonatal fibers became inexcitable. Depression of APA and v~,, was significantly less in the younger age group. This result may possibly be explained by: I ) a larger contribution of the sodium current to APA and V , , , in the adult Purkinje fiber, 2) maturational differences in the membrane binding of d-sotalol to sodium channels, or 3) maturational differences in the access of drug to receptor sites.
Clinical implications. The contribution of different elements of d-sotalol's electrophysiologic profile to its antiarrhythmic action is complex and needs to be interpreted in light of the developmental maturity and "health" (level of membrane potential) of the cardiac tissue treated. In the younger age group, dsotalol exerts little depressant effect on the sodium current (and presumably conduction) in either normal or depolarized cardiac tissue. Its antiarrhythmic action would thus predominantly depend upon prolongation of cardiac refractoriness.
In normally polarized adult cardiac tissue, the insignificant depressant effect on the sodium current limits the antiarrhythmic action of d-sotalol to prolongation of refractoriness. In contrast, both depression of membrane activity (sodium current) and prolongation of repolarization may contribute to the antiarrhythmic action of d-sotalol. Given our observation that the class 111 effect of d-sotalol is significantly attenuated in depressed cardiac tissue, the local anesthetic effects of d-sotalol, although weak, take on therapeutic advantage for suppressing arrhythmias arising in diseased tissue in adult subjects. However, the almost absent local anesthetic effects observed in the immature age group may limit the therapeutic effectiveness of d-sotalol in this age group to arrhythmias arising in normally polarized tissue.
